Search Results for "SCID"



GlaxoSmithKline, Fondazione Telethon, and Ospedale San Raffaele, Announce EU Regulatory Submission for Gene Therapy to Treat Rare Disease ADA-SCID

GlaxoSmithKline (GSK), Fondazione Telethon, and Ospedale San Raffaele, today announced the submission of a marketing application to the European Medicines Agency (EMA) for a gene therapy (GSK2696273) to treat patients with a rare disease, adenosine deaminase severe combined immunodeficiency syndrome (ADA-SCID), for whom no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available. […]


Read The Rest →





Family Hosts Golf Tournament Benefiting SCID, Angels for Life

The 6th Annual Brandon & Taylor Dahley “REACHING FOR A CURE” Charity Golf Tournament was held Saturday, March 21, 2015 in Lakeland, Florida. More than 65 people participated, and over $22,000 was raised for the SCID, Angels for Life Foundation. John and Heather Smith started SCID, Angels for Life in March of 2008 as a […]


Read The Rest →





FDA Allows Marketing of the First Newborn Screening Test to Help Detect SCID

The U.S. Food and Drug Administration yesterday allowed marketing of the EnLite Neonatal TREC Kit, the first screening test permitted to be marketed by FDA for Severe Combined Immunodeficiency (SCID) in newborns. Click here for the full press release.


Read The Rest →





SCID


Read The Rest →





IDF SCID Initiative Supplemental Materials

SCID Q & A with Sung-Yun Pai, MD IDF ADVOCATE, Spring 2015 Proof Positive: Study Confirms the Need for Early Screening and Intervention for SCID IDF ADVOCATE, Winter 2015 Newborn Screening for Severe Combined Immunodeficiency Progress and Challenges The Journal of the American Medical Association, August 20, 2014 Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009 […]


Read The Rest →





JAMA Publishes New Study Offering Further Validation for Newborn Screening for SCID

The Immune Deficiency Foundation (IDF) applauds a new study published August 19, 2014 in the Journal of the American Medical Association (JAMA) that underscores the importance of newborn screening for Severe Combined Immune Deficiency (SCID), also known as Bubble Boy disease. Jennifer M. Puck, MD, senior author of the study and a renowned SCID expert, […]


Read The Rest →





Two More States Begin Implementation of SCID Newborn Screening

A nine-year study recently released proves the need The Immune Deficiency Foundation (IDF) commends the states of Maine and Rhode Island for adding Severe Combined Immune Deficiency (SCID) to their states’ newborn screening panels, effective August 1, 2014. These states join 21 other states currently screening newborns for SCID, ensuring over two thirds of all […]


Read The Rest →





Experimental Technology Diagnoses Illness in Boy with ADA SCID

Fourteen-year-old Joshua Osborn, a member of the IDF community who was born with ADA SCID, was in a coma after weeks of fluid collecting on his brain for reasons unable to be identified. After physicians attempted all known methods for diagnostic results without success, an experimental new technology was employed with momentous results. Using a […]


Read The Rest →





Webcast Discusses SCID Newborn Screening in France

PerkinElmer features a webcast with Dr. Isabelle Durand-Zaleski of the Paris Health Economics and Health Services Research Unit discussing the cost effectiveness of implementing systematic screening for Severe Combined Immune Deficiency (SCID). It explains the costs of screening all newborns and the cost potentially avoided by an early treatment (e.g. bone marrow transplant). Click here […]


Read The Rest →





PerkinElmer Presents Webinar on Cost Effectiveness of SCID Newborn Screening

On April 17, 2014, PerkinElmer will be presenting a free webcast with Dr. Isabelle Durand-Zaleski of the Paris Health Economics and Health Services Research Unit to discuss the cost effectiveness of implementing newborn screening for Severe Combined Immune Deficiency (SCID). The presentation will look at the costs of screening all newborns and at the cost […]


Read The Rest →